Bangladesh Association of Pharmaceutical Industries (BAPI), the stalwart association of pharmaceutical manufacturers of the country was instituted in 1972, Since then BAPI playing a pivotal role in shaping up the industry. Association's member include large, medium, small, national and foreign companies who together are responsible for manufacturing 96% of the country's pharmaceutical production. This indeed proves the success of BAPI as a responsible and acceptable body.
Prospect of medicine export to CIS countries bright
There is bright prospect of export of standard quality medicines produced in Bangladesh to CIS countries including Uzbekistan and Kazakhstan. Both the countries import 90 per cent of medicines from abroad. Besides, there is also immense potentialities to set up joint venture pharmaceutical industries between Bangladesh and the two CIS countries. This was revealed following a visit to both the countries by as delegation of Bangladesh Association of Pharmaceutical Industries (BAPI) led by its adviser SM Shafiuzzaman from June 28 to July 6. During the visit, the delegation observed that the government should expedite diplomatic activities with the Commonwealth of Independent States (CIS) countries, which achieved independence after breaking apart of the former Soviet Union. The delegation also was of the view that pharmaceutical products of Bangladesh worth over Tk 100 crore could be exported to the CIS countries in future with proper diplomatic efforts, enhancement of competent manpower in Bangladesh’s embassies and in CIS countries where there was no representation of the country. The objective of the visit of Bangladesh pharmaceutical delegation to the CIS countries was to explore and expand markets of medicines produced in the country abroad. During its visit, the Bangladesh delegation held talks with Health Minister of Uzbekistan Prof A Ikramov and high officials of his ministry. It was apprised of the health...